Nvelop Therapeutics Company Profile, Contacts & Intelligence

Nvelop Therapeutics Overview

At Nvelop, we are working to address the complex challenge of effectively delivering genetic medicines to target cells within the body (in vivo) in order to help treat patients with previously undruggable diseases. Our team is advancing two next-generation delivery platforms, started in the labs of our scientific co-founders Dr. David Liu of the Broad Institute of MIT and Harvard, and Dr. Keith Joung formerly of Mass General Hospital. We will use these platforms to build a pipeline of therapeutics internally and to enable strategic partners. We are building a culture and organization to support this important mission, bringing together individuals that thrive in a supportive environment where diverse perspectives and a passion for discovery drive cutting-edge science and breakthrough medicines. Read something that resonates? Reach out to careers@NvelopTx.com.

Headquarters

Cambridge, Massachusetts, United States

Website

www.nveloptx.com

Industry

Biotechnology Research

Founded

2022

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Nvelop Therapeutics Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Nvelop Therapeutics People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Nvelop Therapeutics Workforce Composition

Seniority breakdown across 4 visible profiles.

Compare Similar Companies to Nvelop Therapeutics

Explore companies in related markets and compare their industry and employee estimates.